Goldman Sachs Group Inc Pds Biotechnology Corp Transaction History
Goldman Sachs Group Inc
- $555 Billion
- Q1 2024
A detailed history of Goldman Sachs Group Inc transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 90,474 shares of PDSB stock, worth $265,088. This represents 0.0% of its overall portfolio holdings.
Number of Shares
90,474
Previous 12,486
624.6%
Holding current value
$265,088
Previous $62,000
477.42%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding PDSB
# of Institutions
76Shares Held
7.53MCall Options Held
140KPut Options Held
318K-
Black Rock Inc. New York, NY1.87MShares$5.47 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.59MShares$4.65 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA654KShares$1.92 Million0.0% of portfolio
-
State Street Corp Boston, MA557KShares$1.63 Million0.0% of portfolio
-
Inspirion Wealth Advisors, LLC355KShares$1.04 Million0.23% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $83.4M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...